1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global Markets for Research Antibodies

Global Markets for Research Antibodies

  • January 2015
  • -
  • BCC Research
  • -
  • 136 pages

REPORT HIGHLIGHTS

The global market for research antibodies reached $2 billion in 2013 and nearly $2.2 billion in 2014. This market is expected to reach nearly $3 billion in 2019, registering a compound annual growth rate (CAGR) of 6.2% for the period 2014-2019.

This report provides:

An overview of the global market for antibodies used in research.
Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
Segmentation of the market by geography, product types, research applications, species, and major research area.
Details concerning end user types, purchasing factors, new market trends, and potential growth opportunities that are available.
Discussion on the factors affecting strategies of antibody companies, the effect of research funding, and third-party quality evaluation systems.
Analysis of the competitive landscape and key competitor market shares.

STUDY GOALS AND OBJECTIVES

The aim of this report is to provide detailed market and industry analyses to help readers quantify and qualify the global market for research antibodies. Important trends in the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2019.
This report focuses on the market side rather than the technical side. The detailed market segmentation, market shares, major drivers, trend analysis and forecasts for the entire research antibody market are analyzed. In particular, this report includes:
l An overview of the global market for antibodies used in research.
l Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
l Segmentation of the market by geography, product types, research applications, species and major research area.
l Details concerning end users, purchasing factors, new market trends and potential growth opportunities.
l Discussion of the factors affecting strategies of antibody companies, the effect of research funding and third-party quality evaluation systems.
l Analysis of the competitive landscape and market shares for the key players.
l Comprehensive company profiles of the major players in the research antibody field.

REASONS FOR DOING THIS STUDY

Detailed market and industry analysis for the research antibody market is needed. The research antibody market reports available are more focused on analysis of end users’ surveys, customer needs and the overall antibody market. There is no detailed market segmentation and trend analysis for each market segment.
In fact, the research antibody industry is also at a critical time for a revolutionary or breakthrough change. New technologies for antibody generations are emerging, and new research needs, including those for new targets, higher specificity and higher sensitivity, etc., are increasing. More importantly, improving scientific reproducibility, including improving the lot-to-lot consistency of research reagents such as antibodies, is being emphasized by all related communities. Those antibody suppliers who hold proprietary technologies in making antibodies with the lot-to-lot consistency will probably be able to better meet the market needs. So, will the research antibody market stick with the current situation or will a breakthrough occur in the next five to ten years? Are there still any opportunities for new entries in a market that has been crowded with hundreds of big and small suppliers? How much will the current competitive landscape of the research antibody market change over the next five years? This report will provide useful information, analysis and forecasts to help you find the answers to these questions.

Since the first generation of monoclonal antibodies in 1975, the antibody industry has evolved to a prosperous one today. The research sector of the antibody industry is the smallest of the three sectors of the antibody industry, the other two being the diagnostic and therapeutic sectors. However, the research antibody sector is a foundation of the other two. To some degree, detailed analysis of research sectors will also bring about some key hints in the market directions of the diagnostic and therapeutic sectors.
The information in this report can help all antibody suppliers better understand the overall antibody market and the segment of the market they focus on. The detailed analysis and forecasts of the research antibody market can provide useful information for all management levels to help make strategic decisions in related areas.

SCOPE OF REPORT

This study focuses on the market side of research antibodies rather than the technical side. Different market segments for this specific market are covered. For example, application-based market segments include enzyme-linked immunosorbent assay (ELISA), western blotting (WB), immunohistochemistry (IHC), immunofluorescent staining (IF) and flow cytometry (FC); antibody function-based market segments include primary antibodies and secondary antibodies; antibody clonality-based market segments include polyclonal antibodies and monoclonal antibodies, including oligoclonal antibodies; customer type-based market segments include universities/academic institutions, pharmaceutical/biotech companies and other types of customers such as governmental research labs and CROs; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also extrapolated by analyzing the funding, patent publications and sales trends of major players in the field.

Table Of Contents

Global Markets for Research Antibodies
Chapter- 1: INTRODUCTION - Complimentary 4

STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
METHODOLOGY
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: MARKET SUMMARY 3

KEY DRIVERS FOR MARKET GROWTH

Chapter- 3: OVERVIEW OF THE RESEARCH ANTIBODY MARKET 14

INTRODUCTION
HISTORY AND CURRENT STATE
OVERVIEW OF ANTIBODY TECHNOLOGY

Chapter- 4: RESEARCH APPLICATIONS OF ANTIBODIES 15

INTRODUCTION
ELISA/ELISPOT
WESTERN BLOT
IMMUNOHISTOCHEMISTRY
FLOW CYTOMETRY (INCLUDING CELL SORTING)
IMMUNOCYTOCHEMISTRY/IMMUNOFLUORESCENT STAINING
CHROMATIN IMMUNOPRECIPITATION
OTHER APPLICATIONS OF ANTIBODIES

Chapter- 5: SEGMENTATION OF AND FORECAST FOR THE RESEARCH ANTIBODY MARKET 46

RESEARCH ANTIBODY MARKET OVERVIEW
TYPES OF RESEARCH ANTIBODIES
MAJOR PLAYERS
MARKET SEGMENTS BY REGION
SEGMENTS BY PRODUCT TYPE
SEGMENTS BY REACTIVE SPECIES
SEGMENTS BY HOST SPECIES
SEGMENTS BY CLONALITY TYPE
SEGMENTS BY CONJUGATE
SEGMENTS BY RESEARCH AREA
SEGMENTS BY APPLICATION
SEGMENTS BY USER TYPE
PITFALLS IN THE CURRENT RESEARCH ANTIBODY MARKET
MARKET PROJECTIONS

Chapter- 6: APPLICATION-BASED MARKETS FOR RESEARCH ANTIBODIES 4

APPLICATION-BASED MARKET OVERVIEW
MARKET FOR WESTERN BLOT ANALYSIS
MARKET FOR ELISA
MARKET FOR IMMUNOHISTOCHEMISTRY
MARKET FOR IMMUNOFLUORESCENT STAINING

Chapter- 7: MARKET FOR FLOW CYTOMETRY ANALYSIS 5

MARKET OVERVIEW
TRENDS IN FLOW CYTOMETRIC ANALYSIS
MARKET FOR FLOW CYTOMETRY INSTRUMENTS
MARKET FOR FLOW CYTOMETRY REAGENTS AND CONSUMABLES
PRODUCT TYPES
MAJOR PLAYERS AND GROWTH STRATEGIES
MARKET SHARE AND PROJECTIONS

Chapter- 8: MARKET FOR CUSTOM ANTIBODY SERVICES 16

MARKET OVERVIEW
TYPES OF SERVICES
MAJOR PLAYERS
MARKET SHARE AND PROJECTIONS

Chapter- 9: MARKET TREND ANALYSIS 10

PURCHASING FACTORS
THIRD-PARTY QUALITY EVALUATION SYSTEMS
RESEARCH GRANTS
JOURNAL CITATIONS
TECHNOLOGICAL TRENDS IN ANTIBODY PRODUCTION AND APPLICATION
MandA ACTIVITIES RELATED TO THE RESEARCH ANTIBODY INDUSTRY

Chapter- 10: DRIVING FORCES AND LIMITING FACTORS OF MARKET GROWTH 4

DRIVING FORCES FOR MARKET GROWTH
FACTORS LIMITING MARKET GROWTH

Chapter- 11: COMPANY PROFILES 15

ABCAM
ABD SEROTEC (BIO-RAD)
ABNOVA
ACTIVE MOTIF
BD BIOSCIENCES
BECKMAN COULTER INC.
BETHYL LABORATORIES INC.
BIOLEGEND
BIO-TECHNE
CELL SIGNALING TECHNOLOGY
DAKO (AGILENT TECHNOLOGIES)
EBIOSCIENCE INC. (A SUBSIDIARY OF AFFYMETRIX)
EMD MILLIPORE
EVEREST BIOTECH LTD.
JACKSON IMMUNORESEARCH LABORATORIES INC.
LIFESPAN BIOSCIENCES INC.
MILTENYI BIOTEC GMBH
MORPHOSYS AG
ORIGENE TECHNOLOGIES
PROTEINTECH GROUP INC.
ROCKLAND IMMUNOCHEMICALS INC.
SANTA CRUZ BIOTECHNOLOGY INC.
SIGMA-ALDRICH CORP.
THERMO FISHER SCIENTIFIC INC.
UNITED STATES BIOLOGICAL

List of Tables

Summary Table : GLOBAL RESEARCH ANTIBODY MARKET BY REGION, THROUGH 2019
Table 1 : DISTRIBUTION OF ANTIBODY SUPPLIERS BY REGION, AS OF OCTOBER 2014
Table 2 : DISTRIBUTION OF ANTIBODY SUPPLIERS BY STATE IN THE U.S., AS OF OCTOBER 2014
Table 3 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY REGION, THROUGH 2019
Table 4 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019
Table 5 : U.S. MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019
Table 6 : EUROPE MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019
Table 7 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019
Table 8 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, THROUGH 2019
Table 9 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019
Table 10 : U.S. MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019
Table 11 : EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019
Table 12 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019
Table 13 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, THROUGH 2019
Table 14 : GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019
Table 15 : U.S. MARKETS FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019
Table 16 : EUROPEAN MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019
Table 17 : ASIA-PACIFIC MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019
Table 18 : REST OF WORLD MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, THROUGH 2019
Table 19 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019
Table 20 : U.S. MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019
Table 21 : EUROPE MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019
Table 22 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019
Table 23 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, THROUGH 2019
Table 24 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019
Table 25 : U.S. MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019
Table 26 : EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019
Table 27 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019
Table 28 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, THROUGH 2019
Table 29 : U.S. RESEARCH ANTIBODY MARKET BY MAJOR RESEARCH AREA, THROUGH 2019
Table 30 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019
Table 31 : U.S. MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019
Table 32 : EUROPE MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019
Table 33 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019
Table 34 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY APPLICATION, THROUGH 2019
Table 35 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019
Table 36 : U.S. MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019
Table 37 : EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019
Table 38 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019
Table 39 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY END-USER TYPE, THROUGH 2019
Table 40 : MARKET FOR WESTERN BLOT ANTIBODIES BY REGION, THROUGH 2019
Table 41 : MARKET FOR ELISA ANTIBODIES BY REGION, THROUGH 2019
Table 42 : MARKET FOR IHC ANTIBODIES BY REGION, THROUGH 2019
Table 43 : MARKET FOR ICC/IF ANTIBODIES BY REGION, THROUGH 2019
Table 44 : MARKET FOR FLOW CYTOMETRY ANTIBODIES BY REGION, THROUGH 2019
Table 45 : MAJOR SUPPLIERS FOR CUSTOM ANTIBODY SERVICES
Table 46 : DISTRIBUTION OF SUPPLIERS FOR CUSTOM ANTIBODY SERVICES, BY REGION
Table 47 : DISTRIBUTION OF ANTIBODY SUPPLIERS BY STATE IN THE U.S. (AS OF NOVEMBER 2014)
Table 48 : MARKET FOR ANTIBODY CUSTOM SERVICES BY REGION, THROUGH 2019
Table 49 : MOST CITED ANTIBODIES AND THEIR SUPPLIERS

List of Figures

Summary Figure : GLOBAL RESEARCH ANTIBODY MARKET BY REGION, 2013-2019
Figure 1 : GLOBAL RESEARCH ANTIBODY MARKET SHARES BY REGION, 2013-2019
Figure 2 : GLOBAL RESEARCH ANTIBODY MARKET SHARES BY REGION, 2013
Figure 3 : GLOBAL RESEARCH ANTIBODY MARKET SHARE BY REGION, 2019
Figure 4 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019
Figure 5 : U.S. MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019
Figure 6 : EUROPE MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019
Figure 7 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019
Figure 8 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY PRODUCT TYPE, 2013-2019
Figure 9 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019
Figure 10 : U.S. MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019
Figure 11 : EUROPE MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019
Figure 12 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019
Figure 13 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY MAJOR REACTIVE SPECIES, 2013-2019
Figure 14 : GLOBAL MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019
Figure 15 : GLOBAL MARKET SHARE FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2019
Figure 16 : U.S. MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019
Figure 17 : EUROPEAN MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019
Figure 18 : ASIA-PACIFIC MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019
Figure 19 : REST OF WORLD MARKET FOR POLYCLONAL ANTIBODIES BY HOST SPECIES, 2013-2019
Figure 20 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019
Figure 21 : U.S. MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019
Figure 22 : EUROPE MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019
Figure 23 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019
Figure 24 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY CLONALITY, 2013-2019
Figure 25 : GLOBAL MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019
Figure 26 : U.S. MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019
Figure 27 : EUROPEAN MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019
Figure 28 : ASIA-PACIFIC MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019
Figure 29 : REST OF WORLD MARKET FOR RESEARCH ANTIBODIES BY DERIVATIVE FORM, 2013-2019
Figure 30 : GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY APPLICATION, 2013
Figure 31 : GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY APPLICATION, 2019
Figure 32 : GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY END-USER TYPE, 2013
Figure 33 : GLOBAL MARKET SHARE FOR RESEARCH ANTIBODIES BY END-USER TYPE, 2019
Figure 34 : DISTRIBUTION OF SUPPLIERS FOR CUSTOM ANTIBODY SERVICES, BY COUNTRY
Figure 35 : MARKET SHARE OF ANTIBODY CUSTOM SERVICES BY REGION, 2013
Figure 36 : MARKET SHARE OF ANTIBODY CUSTOM SERVICES BY REGION, 2019

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

2016 Europe Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Spain, UK

  • $ 12800
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800. VPGMarketResearch’s new report is a study of the major business opportunities emerging in the European cance ...

R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.